HomeCompareVRAR vs JEPQ

VRAR vs JEPQ: Dividend Comparison 2026

VRAR yields 377.57% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRAR wins by $7521.26M in total portfolio value
10 years
VRAR
VRAR
● Live price
377.57%
Share price
$0.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7521.31M
Annual income
$4,944,975,138.14
Full VRAR calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — VRAR vs JEPQ

📍 VRAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRARJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRAR + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRAR pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRAR
Annual income on $10K today (after 15% tax)
$32,093.64/yr
After 10yr DRIP, annual income (after tax)
$4,203,228,867.42/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, VRAR beats the other by $4,203,227,037.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRAR + JEPQ for your $10,000?

VRAR: 50%JEPQ: 50%
100% JEPQ50/50100% VRAR
Portfolio after 10yr
$3760.68M
Annual income
$2,472,488,645.36/yr
Blended yield
65.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VRAR right now

VRAR
Analyst Ratings
3
Buy
Consensus: Buy
Price Target
$12.00
+2165.4% upside vs current
Range: $12.00 — $12.00
Altman Z
-5.6
Piotroski
1/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRAR buys
0
JEPQ buys
0
No recent congressional trades found for VRAR or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRARJEPQ
Forward yield377.57%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$7521.31M$44.8K
Annual income after 10y$4,944,975,138.14$2,152.59
Total dividends collected$7280.40M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VRAR vs JEPQ ($10,000, DRIP)

YearVRAR PortfolioVRAR Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$48,457$37,757.22$11,930$1,110.39+$36.5KVRAR
2$222,841$170,991.59$14,133$1,224.34+$208.7KVRAR
3$973,338$734,898.24$16,632$1,340.46+$956.7KVRAR
4$4,041,410$2,999,938.35$19,454$1,457.97+$4.02MVRAR
5$15,965,510$11,641,201.73$22,626$1,576.08+$15.94MVRAR
6$60,062,851$42,979,755.42$26,175$1,694.09+$60.04MVRAR
7$215,380,765$151,113,513.41$30,133$1,811.32+$215.35MVRAR
8$736,888,664$506,431,246.00$34,531$1,927.17+$736.85MVRAR
9$2,407,787,131$1,619,316,260.18$39,403$2,041.08+$2407.75MVRAR
10$7,521,307,368$4,944,975,138.14$44,787$2,152.59+$7521.26MVRAR

VRAR vs JEPQ: Complete Analysis 2026

VRARStock

The Glimpse Group, Inc., a virtual reality (VR) and augmented reality (AR) platform company, provides enterprise-focused software, services, and solutions in the United States. It offers QReal, a software that creates and distributes photorealistic 3D and AR content; Adept XR Learning, which provides higher education learning and corporate VR training solutions; PostReality, a cloud-based software as a service solution that enables users to create AR presentations; and XR Platform, a cloud-based, scalable and secure backend infrastructure, including proprietary cloud image recognition technology, online storage, creation and management of subscription plans, and invoicing and payments designed for VR/AR companies. The company also provides D6 VR, a VR-based, analysis, presentation, and education software platform; Immersive Health Group, a digital health platform that leverages VR/AR technology to simplify and streamline complex healthcare challenges in scale; Foretell Reality, an enterprise-grade and easy-to-use solution for meeting others in VR; and Early Adopter, which offers immersive VR and AR EdTech solutions for K-12 schools and pediatric hospital programs. In addition, it offers AUGGD that provides AR software and services primarily for the architecture, engineering, and construction industries; Glimpse Turkey for developing and creating web optimized 3D models, primarily for QReal; and custom specialized AR applications, and white label solutions and services. Further, the company provides Pagoni VR that offers VR video broadcasting solutions, which consists of Chimera that enables real-time communications between a presenter, and local and remote attendees in VR to universities, enterprise, entertainment venues, sports venues, and houses of worship. The company was incorporated in 2016 and is headquartered in New York, New York.

Full VRAR Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this VRAR vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRAR vs SCHDVRAR vs JEPIVRAR vs OVRAR vs KOVRAR vs MAINVRAR vs XYLDVRAR vs QYLDVRAR vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.